相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Shedding of the endothelial receptor tyrosine kinase Tie2 correlates with leukemic blast burden and outcome after allogeneic hematopoietic stem cell transplantation for AML
Christian Koenecke et al.
ANNALS OF HEMATOLOGY (2010)
Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
Anurag Purushothaman et al.
BLOOD (2010)
Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
Keiji Shimada et al.
CANCER SCIENCE (2010)
A Disintegrin and Metalloproteinase 17 (ADAM17) Mediates Inflammation-induced Shedding of Syndecan-1 and-4 by Lung Epithelial Cells
Jessica Pruessmeyer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Receptor Activator of NF-κB (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 Macrophages
Akihiro Hakozaki et al.
JOURNAL OF IMMUNOLOGY (2010)
Crystal Structure of the LasA Virulence Factor from Pseudomonas aeruginosa: Substrate Specificity and Mechanism of M23 Metallopeptidases
James Spencer et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Expression and prognostic role of syndecan-2 in prostate cancer
A. Popovic et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease Patients
A. Bleakley Chandler et al.
THROMBOSIS RESEARCH (2010)
Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines
Kazutaka Hayashida et al.
BLOOD (2009)
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Viktoriya Nikolova et al.
CARCINOGENESIS (2009)
Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer's disease
Ling Zhang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
The signaling mechanisms of syndecan heparan sulfate proteoglycans
Kathleen Lambaerts et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus
Jing-bo Wang et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2009)
Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor κB
Jeong-Hyun Oh et al.
GYNECOLOGIC ONCOLOGY (2009)
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion
Juan Carlos Rodriguez-Manzaneque et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Oxidative Stress Alters Syndecan-1 Distribution in Lungs with Pulmonary Fibrosis
Corrine R. Kliment et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Syndecan-1 Is Required for Robust Growth, Vascularization, and Metastasis of Myeloma Tumors in Vivo
Yekaterina B. Khotskaya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
DeannaLee M. Beauvais et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin Activation
Peter Chen et al.
PLOS ONE (2009)
Serum soluble interleukin 2 receptor in human cancer of adults and children: a review
E. Bien et al.
BIOMARKERS (2008)
Membrane Type 1 Matrix Metalloproteinase-Mediated Stromal Syndecan-1 Shedding Stimulates Breast Carcinoma Cell Proliferation
Gui Su et al.
CANCER RESEARCH (2008)
Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer
Ferdinando Mannello et al.
CANCER SCIENCE (2008)
TβRIII suppresses non-small cell lung cancer invasiveness and tumorigenicity
Elizabeth C. Finger et al.
CARCINOGENESIS (2008)
A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
Angela Raucci et al.
FASEB JOURNAL (2008)
Cellular roles of ADAM12 in health and disease
Marie Kveiborg et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation
Abdo J. Najy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by Metalloproteinases
Ling Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Loss of type III transforming growth factor β receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression
Kelly J. Gordon et al.
CARCINOGENESIS (2008)
Synergistic control of cell adhesion by integrins and syndecans
Mark R. Morgan et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Heparanase enhances syndecan-1 shedding - A novel mechanism for stimulation of tumor growth and metastasis
Yang Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9
Severine Brule et al.
GLYCOBIOLOGY (2006)
Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells
Constance Y. Fears et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation
Fengqiang Wang et al.
CANCER LETTERS (2006)
Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: A proposed mechanism for stabilization of extracellular lipoprotein lipase
Ofer Reizes et al.
BIOCHEMISTRY (2006)
Syndecan-1 expression by stromal. broblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis
T Maeda et al.
ONCOGENE (2006)
Enzymatic remodeling of heparan sulfate proteoglycans within the tumor microenvironment: Growth regulation and the prospect of new cancer therapies
RD Sanderson et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells
K Ding et al.
JOURNAL OF CELL BIOLOGY (2005)
Syndecan-1 expression in locally invasive and metastatic prostate cancer
D Chen et al.
UROLOGY (2004)
Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer
EJ Davies et al.
CLINICAL CANCER RESEARCH (2004)
Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration
K Endo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells
VK Asundi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells
H Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Heparanase-1 expression is associated with the metastatic potential of breast cancer
JB Maxhimer et al.
SURGERY (2002)
Syndecan-4 and focal adhesion function
A Woods et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Evidence of a role for a non-matrix-type metalloproteinase activity in the shedding of syndecan-1 from human myeloma cells
I Holen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase
ML Fitzgerald et al.
JOURNAL OF CELL BIOLOGY (2000)
Syndecan-1 shedding is enhanced by LasA, a secreted virulence factor of Pseudomonas aeruginosa
PW Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)